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The Sendai virus RNA polymerase is a complex of two virus-encoded proteins, the phosphoprotein (P) and the large (L)
protein, where L is believed to possess all the enzymatic activities necessary for viral transcription and replication. The
alignment of amino acid sequences of L proteins from negative-sense RNA viruses shows six regions, designated domains
I–VI, of good conservation which have been proposed to be important for the various enzymatic activities of the polymerase.
To directly address the role(s) of domains II and III, site-directed mutations were constructed by the substitution of multiple
amino acids at 13 highly or mostly conserved residues. Analysis of in vitro viral transcription and replication showed that the
majority of the mutations completely inactivated the L protein for all aspects of RNA synthesis, thus conservation correlated
with the essential nature of the amino acid. At some positions different phenotypes, from inactivation to partial activities,
were observed which depended on the nature of the amino acid that was substituted. Two mutants, K543R and K666V, could
synthesize some leader RNA, but were defective in mRNA synthesis and replication. K666R and G737E had significantly
reduced replication compared to transcription in vitro, but replicated genome RNA much more efficiently in vivo. K666A gave
transcription, but no replication. Representative inactive L mutants, however, were still able to bind P protein and theINTRODUCTION
The RNA-dependent RNA polymerase of nonseg-
mented, negative ()-strand RNA viruses consists of a
complex of two subunits, the phosphoprotein (P) and the
large (L) protein (Lamb and Kolakofsky, 2001). This en-
zyme catalyzes a variety of reactions that in eukaryotic
transcription require multiple multi-subunit enzyme com-
plexes. The P–L complex is unusual first in that the
template for all RNA synthesis is the nucleocapsid, the
()-strand genome RNA encapsidated in the viral nu-
cleocapsid (NP) protein, and not naked RNA. The viral
polymerase synthesizes first a ()-strand leader (le)
RNA from the 3 end of the template, followed by the
sequential synthesis of the individual monocistronic
mRNAs. Each mRNA is capped and methylated at the 5
end and polyadenylated at the 3 end. Replication of both
()- and ()-strand full-length genome RNA involves the
concurrent synthesis of RNA and its encapsidation with
NP protein, a method of packaging catalyzed by the
polymerase that is very different from particle formation
in other classes of viruses.
1 To whom correspondence and reprint requests should be ad-
dressed at Department of Molecular Genetics and Microbiology, Uni-
versity of Florida College of Medicine, P.O. Box 100266, 1600 S.W.135In the Sendai virus model system studied here, the L
[2228 amino acids (aa)] and P (568 aa) proteins must be
coexpressed to form the functional polymerase complex
(Horikami et al., 1992), because L protein is unstable in
the absence of P (Horikami et al., 1997). L protein alone
is unable to bind to the nucleocapsid template and bind-
ing of the P–L complex occurs instead through a P–nu-
cleocapsid interaction (Ryan and Kingsbury, 1988; Ryan
and Portner, 1990). The L subunit is believed to contain
all the catalytic activities associated with the polymerase
(Einberger et al., 1990; Hammond and Lesnaw, 1987;
Hammond et al., 1992; Hercyk et al., 1988; Hunt and
Hutchinson, 1993; Poch et al., 1990). When the amino
acid sequences of L proteins from a variety of ()-strand
RNA viruses were compared (Poch et al., 1990; Sidhu et
al., 1993), six regions of good conservation, designated
domains I to VI, were identified. It was proposed that
these conserved domains mediate the enzymatic activi-
ties of the L protein, while the more variable regions
between the domains contribute to the overall conforma-
tion of the protein. For domains II, III, and VI the analysis
revealed regions of homology with motifs found in other
well-characterized polymerase proteins. In Sendai L do-
main II (aa 503–607), for example, there is a highly
charged putative RNA-binding motif. Site-directed mu-polymerase complex was capable of binding nucleocapsid
© 2002 Elsevier Science (USA)
Archer Road, Gainesville, FL 32610. Fax: (352) 846-2042. E-mail:
smoyer@ufl.edu.
doi:10.1006/viro.2002.1644e defect appeared to be in the initiation of RNA synthesis.
tagenesis of several highly conserved amino acids in
this motif completely inactivated all but one of the pro-
0042-6822/02 $35.00s, so th© 2002 Elsevier Science (USA)
All rights reserved.
teins, showing that most, but not all, of these residues
were essential for all viral RNA synthesis (Smallwood et
al., 1999). Domain III (aa 653–876) contains a potential
GDNQ phosphodiester bond-forming motif, which was
shown to be essential for the VSV, rabies, and bunyavirus
L proteins (Jin and Elliot, 1992; Schnell and Conzelman,
1995; Sleat and Banerjee, 1993), as all mutations within
this motif abolished viral RNA synthesis. Domain VI (aa
1770–1847) contains a putative nucleotide-binding motif.
While a few mutagenesis studies have been under-
taken on domains II and III in several different ()-strand
RNA viruses, these involved relatively few amino acid
changes in only a few of the most highly conserved
residues (Jin and Elliot, 1992; Schnell and Conzelman,
1995; Sleat and Banerjee, 1993; Smallwood et al., 1999).
We have extended these analyses to study the function
of these domains by site-directed mutagenesis of other
conserved amino acids in these regions. The approach
was to change 13 highly or mostly conserved selected
residues to multiple different amino acids (from 2 to 8) to
understand the importance of both the position and the
type of residue for the function of the L protein.
RESULTS
Mutations in domains II and III have a range of
effects on the synthesis of Sendai L protein
Site-directed mutations substituting one or multiple
amino acids at 2 residues in domain II and at 11 residues
in domain III were constructed in the Sendai L gene as
described under Materials and Methods. To first confirm
that the L proteins were being synthesized, sets of VVT7-
infected cells were transfected with wild-type (wt) P and
the wt or mutant L plasmids and radiolabeled with 35S-
labeled amino acids overnight. Cytoplasmic extracts
were prepared, immunoprecipitated, and analyzed by gel
electrophoresis. The majority of the L mutants were full
length and synthesized in steady-state amounts similar
to the wt L protein in each set (Fig. 1). Two of the
changes, R736P (Fig. 1C, Lane 13) and G741A (Fig. 1D,
Lane 12), however, did not yield any detectable L protein,
even with transfection of increasing amounts of L plas-
mid (not shown). These changes clearly adversely af-
fected the stability of the protein. Several other mutant L
proteins were synthesized in significantly reduced
steady-state amounts including Y540E and Y540Q (Fig.
1A, Lanes 3 and 5); T661E and D663Y (Fig. 1B, Lanes 6
and 11, respectively); and R736D (Fig. 1C, Lane 11). The
P protein was equally expressed with each of the L
mutants.
The majority of the mutations in the Sendai L protein
inactivate viral mRNA synthesis
The L mutants were then tested for their ability to
synthesize viral mRNA in vitro. VVT7-infected cells were
transfected with wt P and wt or mutant L plasmids,
incubated overnight, and cytoplasmic cell extracts were
FIG. 1. Expression of the domain II and III Sendai L mutants. (A–D) A549 cells were infected with VVT7 and transfected either with no plasmids
(Mock) or with wt P/C plus the indicated wt or mutant L plasmids. Two independent clones of K543N, K543N-1, and K543N-2 (A) were analyzed. The
cells were labeled overnight with Tran35S-label. Cytoplasmic extracts were immunoprecipitated with -P and -L antibodies and analyzed by
SDS–PAGE as described under Materials and Methods. The positions of the P and L proteins are indicated.
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prepared as described under Materials and Methods.
The extracts were incubated with polymerase-free wt
Sendai RNA-NP template in the presence of [32P]CTP
and the total mRNA products was analyzed. The wt
Sendai L and P proteins gave good synthesis of viral
mRNA (Figs. 2A–2D, Lanes 2), while no synthesis was
seen using extracts from cells that were infected, but not
transfected (Lanes 1), showing that the template alone
had no associated polymerase and activity was depen-
dent on added polymerase. As a control for the mutagen-
esis procedure, several mutants were changed back to
the wt amino acid and designated E740E, K543K, and
K666K, and each of these gave wt levels of mRNA syn-
thesis as expected (Fig. 2C, Lane 12; Fig. 2D, Lanes 3
and 4, respectively). Most of the L mutations completely
abolished mRNA synthesis (Figs. 2A–2D); however, a few
retained variable amounts of activity. Of the three substi-
tutions at Y540 in domain II only the conservative change
Y540F gave partial (31%) activity, while the other two,
Y540E and Y540Q, which both had lower levels of protein
(Fig. 1A), were inactive (Fig. 2A, Lane 3; Fig. 2B, Lanes 3
and 4). All 10 of the changes at K543 in domain II, which
showed good L protein expression (Fig. 1), gave no
mRNA synthesis (Fig. 2A). Even the conservative change
K543R was inactive, so specifically lysine at this position
is essential. Similarly, all five substitutions at D663 and
the two changes at T661, both in domain III, gave no
mRNA synthesis (Fig. 2B, Lanes 5–9; Fig. 2C, Lanes 3
and 4), although only T661E and D663Y were reduced in
the amount of L produced (Fig. 1). Thus most of these
conserved residues were essential for viral transcription.
The five substitutions at K666, a position completely
conserved in the L proteins of paramyxo- and rhabdovi-
ruses (Poch et al., 1990; Sidhu et al., 1993), gave inter-
esting effects on the activity of the protein. K666R and
K666A gave partial mRNA synthesis (18–24%) compared
to wt L, while replacement with leucine, valine, and
glycine virtually abolished synthesis (Fig. 2B, Lanes 10–
14). Enzymatic activity was thus sensitive to the nature of
the amino acid replacement at this position. Similar re-
sults were obtained for three changes at C668 which is
conserved in L proteins of paramyxoviruses. Substitu-
tions of leucine and lysine gave inactive L proteins, while
replacement with tyrosine retained significant (66%)
FIG. 2. In vitro mRNA synthesis with the domain II and III Sendai L mutants. (A–D) VVT7-infected cells were transfected with either no plasmids
(Mock) or with wt P/C plus the indicated wt or mutant L plasmids. Two independent clones of K543N, K543N-1, and K543N-2 (A) were analyzed.
Cytoplasmic extracts of the cells were incubated with polymerase-free Sendai RNA-NP template in the presence of [32P]CTP. Labeled RNA products
were purified and separated by gel electrophoresis as described under Materials and Methods. The position of the NP and P mRNAs, which
comigrate, is indicated. Western blot analysis showed that the P protein was equally synthesized with each L protein (data not shown). The
percentage of mRNA synthesis as an average of three experiments is shown below compared to wt L as 100%.
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mRNA synthesis (Fig. 2C, Lanes 5–7). The N734E change
also gave activity (59%, Fig. 2D, Lane 5) consistent with
this being a nonconserved position in the protein. In
addition, for the seven substitutions at R736, a less-
conserved residue in L proteins, a spectrum of activities
was also observed. Changes to aspartic acid, proline,
and glutamic acid at aa 736 abolished mRNA synthesis
(Fig. 2C, Lanes 8, 10, 11) due probably for the first two to
their severely reduced protein levels (Fig. 1). Substitu-
tions of valine and leucine gave limited activity (10–16%),
but a change to methionine was nearly at wt L levels
(87%) (Fig. 2C, Lane 9; Fig. 2D, Lanes 6 and 7).
In domain III there are several clusters of nearly in-
variant amino acids and we chose one from Sendai L at
aa 737–752 (GGIEGYCQKLWTLISI) to do site-directed
mutagenesis at aa 737, 738, 740, 741, and 744. Except for
G741R the mutant L proteins were all expressed (Fig. 1).
One change G737A was inactive and the mutant G737E
gave very small (2%) activity (Fig. 2D, Lanes 9 and 10).
The rest of the mutants were all completely inactive in
viral mRNA synthesis in vitro (Fig. 2C, Lanes 13 and 14;
Fig. 2D, Lanes 9–13; Table 1). As the conservation sug-
gested, these amino acids are thus all essential for viral
transcription.
The effects of L mutations on the synthesis of le
RNA are similar to the effects on mRNA synthesis
Since most of the L mutations decreased or abolished
the ability of the polymerase to transcribe full-length
mRNAs, we examined the activity of the mutant proteins
in the synthesis of le RNA. The 55-nt le RNA is the
first product of transcription and serves as a measure of
the ability of the polymerase complex to initiate RNA
synthesis. Cells were infected and transfected with wt P
and the wt or mutant L plasmids and extracts were
incubated with Sendai RNA-NP template in the absence
of radiolabeled nucleotides. The total RNA products
were purified and analyzed by Northern blotting with a
radiolabeled le-specific oligonucleotide probe. Wt L
synthesized the 55-nt le RNA along with some longer
products derived by readthrough at the le-NP junction
(Vidal and Kolakofsky, 1989; Horikami and Moyer, 1995),
while no products were seen in the mock extracts (Figs.
3A and 3B, Lanes 1 and 2). Representative examples of
L mutants that synthesized little or no mRNA were also
tested. The L mutants K543R and K666V, with 0 and 2%
mRNA synthesis, respectively (Table 1), actually did syn-
thesize more (7 and 13%) of the 55-nt le RNA (Fig. 3A,
Lane 4; Fig. 3B, Lane 4). These mutants started synthesis
at the end of the genome at low levels, but apparently
were impaired in the initiation of mRNA synthesis at the
leader-NP gene boundary. Most of the mutants gave
either no or a trace amount (0.1%) of le RNA synthesis
(Fig. 3) corresponding to their lack of mRNA synthesis.
K737E gave similar low amounts (2%) of the 55-nucleo-
tide (nt) le RNA (Fig. 3B, Lane 9) and mRNA synthesis
(Table 1). Thus the majority of the mutant enzymes were
not able to synthesize even the small first transcription
product.
Effect of the L mutations on in vitro DI-H RNA
replication
Representative examples of the mutants at each posi-
tion were also assayed for their ability to replicate a viral
DI-H template in vitro and in vivo. In vitro replication
measures the ability of the viral polymerase to catalyze a
single round of replication using template purified from
DI-H virus. VVT7-infected cells were transfected with
plasmids encoding Sendai wt Pstop, which does not
express the C proteins, and NP and the wt or mutant L
genes, and cytoplasmic extracts of the cells were incu-
bated with polymerase-free DI-H RNA-NP template in the
presence of a radiolabeled nucleotide. The products
were digested with micrococcal nuclease to degrade all
nucleic acids except for NP-encapsidated replication
products, which were purified and separated by gel elec-
trophoresis. The wt L protein directed the synthesis of
TABLE 1
RNA Synthesis by Representative Sendai L Mutants
in Domains II and III
L mutant
Transcription DI-H replication
mRNA Le RNA In vitro In vivo
WT 100 100 100 100
Y540E 0 0 0 0
Y540F 31 ND ND 93
K543R 0 7 0 ND
T661K 0 ND 0 0
D663V 0 0 0 0
K666L 0 0.1 0 0
K666R 24 ND 6 63
K666V 2 13 0 0
K666A 18 ND 0 0
C668L 0 0.1 0 0
N734E 74 ND 100 94
R736V 16 ND 50 63
R736E 0 0.1 0 0
R736L 18 ND 57 151
R736M 87 ND 120 99
G737E 2 2 2 22
G738F 0 0.1 0 0
E740S 0 0.1 0 0
G741R 0 ND 0 0
Q744K 0 ND 0 0
Note. Extracts of infected, transfected cells containing the wt or
representative mutant L proteins were assayed for mRNA and le RNA
synthesis and for DI-H replication in vitro and in vivo as described in
Figs. 2–5. The data for each assay are the average of three experiments
for each parameter compared with wt L as 100% with 10% variation.
ND, not done. For le RNA synthesis just the 55-nt le band was
quantitated. Mutants at aa 540 and 543 are in domain II and mutants
from aa 661–744 are in domain III.
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the DI-H genome RNA, while there was no product with
the mock extract (Figs. 4A–4C, Lanes 1 and 2), showing
the dependence of replication on added viral proteins.
For the L mutants tested the pattern of replication activity
was generally similar to that seen for transcription, with
a few significant differences. L mutants with the substi-
tutions Y540E, K543R/T, T661K, D663V, C668L/K, G738F,
E740S, G741R, and Q744K, which were all inactive in
transcription (Fig. 2), also synthesized no DI-H RNA (Fig.
4; Table 1). The mutant G737E gave a small amount (2%)
of replication similar to the level of transcription; how-
ever, G737A was inactive in both processes (Fig. 4C,
Lanes 8 and 9, Table 1).
At K666 several substitutions had different effects on
replication. Although K666A and K666R both gave some
transcription (20%, Table 1), the former gave no DI-H
replication, while K666R synthesized low (6%), but de-
tectable, product (Fig. 4A, Lane 9; Fig. 4B, Lane 6). Thus
replication was more affected by these mutations than
transcription. Another change, K666L, however, com-
pletely inactivated all synthetic activity (Fig. 4B, Lane 5;
Table 1). The significant replicative activity of N734E was
consistent with its level of mRNA synthesis (Table 1). At
R736 the changes to valine, leucine, and methionine
gave good replicative activity (Fig. 4C, Lanes 4, 6 and 7;
Table 1), but the change to a positively charged amino
FIG. 3. Synthesis of le RNA by the domain II and III Sendai L mutants. (A–B) VVT7-infected cells were transfected with no plasmids (Mock) or
with wt P/C plus the indicated wt or mutant L plasmids. Cytoplasmic extracts of the cells were incubated with polymerase-free Sendai RNA-NP
template. Unlabeled total products were purified, separated by gel electrophoresis, and detected by Northern blot analysis using a le-specific
oligonucleotide probe as described under Materials and Methods. The positions of the 55 nt le product and the xylene cyanol (xc) and bromphenol
blue (bpb) dyes are indicated.
FIG. 4. In vitro DI-H RNA replication with the domain II and III Sendai L mutants. (A–C) VVT7-infected cells were transfected either with no plasmids
(Mock) or with Pstop and NP and the indicated wt or mutant L plasmids. Cytoplasmic extracts were incubated with polymerase-free DI-H RNA-NP
template in the presence of [32P]CTP and then digested with micrococcal nuclease. Nuclease-resistant labeled replication products were separated
by gel electrophoresis as described under Materials and Methods. Western blot analysis showed that the P and NP proteins were equally synthesized
with each L protein (data not shown). The position of the DI-H RNA is indicated.
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acid in R736D and R736E abolished both activities (Fig.
4C, Lanes 3 and 5). Two mutants, R736V and R736L, gave
significantly more replication than transcription in vitro.
This is not a phenotype that we have previously ob-
served. The probable explanation for this phenotype is
that the source of the P protein is different between these
experiments, where for mRNA synthesis a plasmid was
used, which expresses both the P and the C proteins and
for replication a plasmid, Pstop, that only expressed P
was used. Since the C proteins have been shown to
inhibit all viral RNA synthesis (Curran et al., 1992; Cadd
et al., 1996; Tapparell et al., 1997; Horikami et al., 1997),
we assayed all the mutants for transcription with Pstop.
All the mutants that were inactive for mRNA synthesis
with P/C were also completely inactive with Pstop (data
not shown). Each mutant that gave some level of mRNA
synthesis with P/C gave increased levels (three- to four-
fold) with Pstop, so for R736V and R736L transcription
and replication in vitro are actually very similar (Table 1).
The absence of the C proteins exaggerates the differen-
tial between mRNA synthesis and the reduction or ab-
sence of replication for K666R, K666A, and G737E (not
shown).
Effect of the L mutations on in vivo DI-H replication
An in vivo method for assaying the replication capac-
ities of the mutant L proteins measures the ability of the
viral polymerase to direct multiple rounds of replication
from a DI-H template synthesized in the transfected cell.
VVT7-infected cells were transfected with plasmids en-
coding wt Pstop, NP, and the wt or representative mutant
L plasmids, along with pSPDI-H, the DI-H genomic plas-
mid (Myers and Moyer, 1997), or with pSPDI-H alone
(Mock). T7 RNA polymerase transcribes the DI-H plas-
mid to generate full-length () sense DI-H genomic RNA,
which has an authentic 3 end due to the action of the
hepatitis delta ribozyme at the end of the primary tran-
script. DI-H transcripts nonspecifically encapsidated by
the NP protein then serve as a template for the viral
polymerase to synthesize encapsidated ()-sense DI-H
RNA, the template for further rounds of replication. After
overnight incubation cytoplasmic extracts of the cells
were digested with micrococcal nuclease to degrade all
nucleic acids except for encapsidated RNA replication
products and ()-sense DI-H RNA was detected by
Northern blot analysis with a ()-sense DI-H-specific
riboprobe. The positive control with wt L showed good
DI-H RNA replication, while in the negative control trans-
fected with pSPDI-H alone there is no replication (Figs.
5A and 5B, Lanes 1 and 2), as expected. The mutants
Y540E, T661K, K666A/V, C668L/K, R736E, and G738F (Fig.
5) and D663V, E740S, G741R, and Q744K (not shown)
were completely inactive in replication in vivo, as they
were in vitro (Table 1). The substitution mutants Y540F,
N734E, and R736V/L/M that had given some in vitro DI-H
replication also gave similar replicative activity in vivo
(Fig. 5A, Lanes 4, 10, 11; Fig. 5B, Lanes 6, 7; Table 1). In
contrast, K666R and G737E actually showed 10-fold
increase in replication in the cell vs in vitro (Fig. 5A, Lane
6; Fig. 5B, Lane 8, Table 1).
The enzymatically inactive L mutants retain the ability
to complex with P protein and the complexes bind to
nucleocapsids
The L protein itself is unable to bind to the template,
but is bound through the P subunit of the P–L complex.
We next determined if an inactive L mutant in domain II
(K543T) and domain III (E740S) (Table 1) was able to
complex with P protein, measured by binding polymer-
ase to the viral template. VVT7-infected cells transfected
with wt P/C and the wt or mutant L plasmids were
labeled with 35S amino acids. Immunoprecipitation
showed that the L proteins were all similarly expressed
(data not shown). Samples were incubated in the ab-
sence or presence of Sendai RNA-NP (NC) and fraction-
ated by centrifugation through glycerol, and the nucleo-
capsid-associated proteins in the pellet analyzed by gel
electrophoresis as described under Materials and Meth-
ods. In addition to some background vaccinia virus or
cellular proteins seen in the mock samples (Fig. 6, Lane
2) for wt L and each of the L mutants, there was a small
amount of the viral proteins which pelleted in the ab-
sence of NC (Fig. 6, odd lanes) which probably repre-
sents some aggregates. The amount of P and both wt
and mutant L in the pellet increased significantly in the
presence of NC (Fig. 6, even lanes), showing the binding
of the K543T and E740S with P to the template. Similar
data (not shown) were obtained for the inactive L mu-
tants T661K, D663V, K666L, and R736E. These results
show that these mutant L proteins did form a polymerase
FIG. 5. In vivo DI-H RNA replication with the domain II and III Sendai
L mutants. (A–B) VVT7-infected cells were transfected with either
pSPDI-H plasmid alone (Mock) or with pSPDI-H plus Pstop and NP and
the indicated wt or mutant L plasmids. K666R was done in duplicate (A,
Lane 6; B, Lane 4). Cytoplasmic extracts were directly digested with
micrococcal nuclease and purified nuclease-resistant replication prod-
ucts analyzed on a Northern blot with a ()-sense DI-H-specific 32P-
labeled riboprobe as described under Materials and Methods. The
position of the DI-H RNA is indicated.
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complex with P protein and the complex bound to the
template, but could not synthesize any RNA.
DISCUSSION
Six conserved domains (I–VI) have been defined
based on amino acid comparisons of the L proteins of a
number of paramyxoviruses and rhabdoviruses (Poch et
al., 1990; Sidhu et al., 1993); however, studies directed at
identifying specific functions for these regions are limit-
ing. Although the P protein of the P–L polymerase com-
plex brings the enzyme to the template by the interaction
of the P subunit with NP of the nucleocapsid, the L
protein must also interact with the template for RNA
synthesis to take place. Domains II and III of L have been
proposed to represent the polymerase module (Mu¨ller et
al., 1994). Domain II contains a region, designated pre-
Motif A, with three invariant amino acids and one highly
conserved charged residue. Domain III contains four
regions designated motifs A, B, C, and D that together
contain four invariant amino acids and one highly con-
served residue when compared to 23 RNA-dependent
RNA or DNA polymerases, including enzymes from
paramyxoviruses, rhabdoviruses, bunyaviruses, arenavi-
ruses, influenza viruses, a filovirus, and HIV (Mu¨ller et al.,
1994). By analogy to the crystal structure of HIV reverse
transcriptase, five residues, E569, D663, D773, N774, and
K848, are proposed to contribute to the palm region, and
four residues, K543, R552, R562, and G741, are proposed
to contribute to the finger region of the Sendai virus L
protein. K543, R552, R562, E569, and G741 are thought to
position the template in the catalytic site. D663, D773,
D774, and K848 seem to be involved in the enzymatic
activity. In the present study seven invariant residues
(D663, K666, G737, G738, E740, G741, and Q744), five
conserved residues (Y540, K543, T661, C668, and R736),
and one nonconserved residue, N734, were investigated
(Fig. 7; Poch et al., 1990; Sidhu et al., 1993). The residues
were changed to several different amino acids (from 2 to
8) by site-directed mutagenesis to analyze the impor-
tance of both the position and the type of group for the
function of the Sendai L protein. From the whole panel,
two mutant proteins were not synthesized (R736P,
G741A) and the synthesis of five mutants (Y540E, Y540Q,
T661E, D663Y, and R736D) was markedly reduced. Thus,
FIG. 7. Alignment of portions of domains II and III for the L proteins
of selected paramyxoviruses and rhabdoviruses. The L proteins were
from the following viruses: Sendai; human parainfluenza 3 (hPIV3);
measles; rinderpest (RPV); phocid distemper (PDV); human parainflu-
enza 2 (hPIV2); simian virus 5 (SV5); mumps; Newcastle disease (NDV);
human respiratory syncytial (hRSV); rabies; and vesicular stomatitis
(VSV-Ind). Domain II consists of Sendai aa 503–607 and shown at the
top are aa 529–549. Domain III consists of Sendai aa 653–873 and
shown below are the portions from aa 653–673 and aa 731–751. The
amino acids that were mutated are shown in bold with an asterisk
above. In the alignment the dots indicate identity and the dash indi-
cates a deletion.
FIG. 6. Nucleocapsid binding of enzymatically inactive domain II and
III Sendai L mutants. VVT7-infected cells were transfected with either
no plasmids (Mock) or with wt P/C and the indicated wt or mutant L
plasmids and labeled overnight with Tran35S-label. Samples of cyto-
plasmic cell extracts were incubated either in the absence () or in the
presence () of wt Sendai RNA-NP template (NC) and separated by
centrifugation as described under Materials and Methods. The nucle-
ocapsid-containing pellets were analyzed by SDS–PAGE. The positions
of the P and L proteins are indicated.
141DOMAIN II AND III MUTATIONS IN SENDAI L PROTEIN
some of the amino acid substitutions had significant
effects on the overall stability of the proteins.
As summarized in Fig. 2 and Table 1, of a total of 47,
only 9 mutants were active, but to different degrees, in in
vitro transcription. Inactive mutants representing differ-
ent important positions whose proteins were synthe-
sized were shown to bind P protein and to bind as a
complex to the nucleocapsid template (Fig. 6), so the
defective transcriptional activity was not due to a simple
binding defect. None of the invariant residues (D663 and
G741) or the almost invariant K543 (22/23) in the 23
polymerases compared by Mu¨ller et al. (1994) could be
changed. In addition, the majority of L proteins mutated
at residues invariant between the polymerases of
Mononegavirales (G738, E740, Q744) were inactive, but
K666R/A/V and G737E gave small or moderate activity. A
comparable result was found when charged-to-ala
changes of the invariant residues within domain II of the
Sendai L protein were performed (Smallwood et al.,
1999). Mutants 2–1 (L542AK543A), 2–5 (K562A), and
2–6 (E569A) were completely inactive, whereas the non-
conservative exchange R552A (2-3) gave 50% of the tran-
scriptional activity of wt L. Mutants Y540F, C668Y, and
R736V/M/L with amino acid exchanges at conserved, but
not invariant, residues or the nonconserved N734E were
able to transcribe viral mRNA up to 87% of wt L.
Representative mutants which exhibited no or moder-
ate activity in the assay for mRNA synthesis were also
tested for leader RNA synthesis. The 55-nt le RNA is
the first product of transcription which indicates that
initiation of RNA synthesis took place. The majority of the
mutant L enzymes do not appear to be able to even make
this product (Table 1). The 55-nt le RNA was observed
for mutant G737E (2% of wt L) in an amount proportional
to mRNA synthesis. Interestingly, mutants K543R and
K666V gave 7 and 13%, respectively, of the 55-nt le
RNA, although these mutants were virtually inactive in
mRNA synthesis. These mutant RNA polymerases
started the catalytic process, but were unable to over-
come the boundary between the leader and NP genes. In
mutant K543R a residue invariant between 22 and 23
polymerases even a conservative change (K  R) de-
stroys all transcriptional and replicative activity except
for polymerase complex formation and synthesis of le
RNA. A similar situation was found with mutant K666V:
residue K666 is invariant between the L proteins of
Mononegavirales, and while conservative or charged-to-
ala exchanges (K666R, K666A) are tolerated for transcrip-
tion, the nonconservative exchanges to val or leu destroy
mRNA synthesis, but retain to some extent the ability to
form le RNA.
K666 is thought to be part of the palm domain of the
catalytic center of the L protein since the neighboring
D663 is only 4.2 Å apart from D773 and N774 of the GDN
motif in the catalytic center (Mu¨ller et al., 1994). Since
K543R is thought to be located far from D666 in the palm
domain, in the finger domain which is responsible for the
interaction of the enzyme with the template strand (Mu¨l-
ler et al., 1994), different regions of the protein are re-
quired for the le, mRNA phenotype. In fact, in previ-
ous studies mutants in domain I (L12, L16, L17) (Chan-
drika et al., 1995), domain IV (SS10) (Feller et al., 2000a),
and domain V (SS21) (Cortese et al., 2000) also have a
similar phenotype, suggesting that these regions are
also involved specifically with sites in domains II and III
in crossing the junction between the leader and NP
genes. Possibly recognition of the start site for mRNA
synthesis is impaired. Alternatively, it is tempting to spec-
ulate that an unknown factor(s) that binds these sites is
required for the polymerase to cross the boundary be-
tween the leader and NP genes. For example, the switch
from transcription to genome replication is controlled by
the presence of the heterodimer NP0-P, which has to bind
to the L polymerase (Curran et al., 1995; Horikami et al.,
1992). A similar mechanism could be involved in the
switch from le RNA synthesis to mRNA synthesis. Bind-
ing of a cofactor might be destroyed within the mutants
K543R and K666V (as well as others), which represent
valuable tools for the characterization of putative cofac-
tors regulating the transcriptional mode of the Sendai
polymerase.
Representative examples of the mutants at each posi-
tion were assayed for their ability to replicate viral DI-H
templates. In a first set of experiments 23 mutants were
tested in an in vitro replication assay which measures
the ability of the viral polymerase to catalyze a single
round of replication using a template purified from DI-H
virus. All mutants which were inactive in transcription
also showed no replication in vitro. Mutant G737E gave
a small signal (2%) similar to that of transcription,
whereas G737A was inactive in both processes. At K666
several substitutions had different effects. Exchanges to
arg or ala were tolerated in mRNA synthesis; however,
only L protein with K666R gave limited replication activity.
The sensitivity of K666 to different substitutions demon-
strates once more the important function of lysine in the
catalytic center of the polymerase. Similar to the domain
III K666A change characterized here, mutants including
domain I (L9, L10, L14) (Chandrika et al., 1995); domain II
(2–3) (Smallwood et al., 1999), domain V (SS17-SS20,
SS22, SS23, L1361Y) (Cortese et al., 2000), and two oth-
ers between domains V and VI (L1558I, C1571Y)
(Horikami and Moyer, 1995; Feller et al., 2000a) all can
transcribe but cannot replicate, thus uncoupling the two
processes. We propose that these mutations abolish the
interaction of the P–L polymerase complex with the
NP0-P substrate which is required for the encapsidation
of the nascent replicative RNA. Since this phenotype was
observed with mutants across L, it suggests that these
regions of the protein are interacting, perhaps constitut-
ing a nonlinear domain by the folding of the polypeptide.
The ability of the polymerase to direct multiple rounds
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of replication from a DI-H template was also examined in
an in vivo replication assay. All the mutants inactive in
vitro were also inactive in vivo. Some of the mutants that
exhibited some in vitro DI-H replication activity showed
enhanced levels of replicative activity in vivo, most strik-
ingly K666R and G737E, with a 10-fold increase. This
phenotype has previously been observed in some L
mutants in other domains, including at aa 1361, and in
SS19 and SS22 in domain V and at aa 1558 between
domains V and VI (Feller et al., 2000b; Cortese et al.,
2000). It appears that some function of the intact cell is
stabilizing these L mutants, a function that is not repro-
duced in cell extracts. One possible explanation is that in
vivo replication is inherently better than that in extracts;
however, we do not observe this phenotype in most other
L mutants, suggesting that some unknown component of
the intact cell can rescue some mutants that are defec-
tive in cell extracts.
Domains II and III of the L protein, which are thought
to be responsible for important functions, e.g., binding of
template and catalytic activity, have now been analyzed
in more detail and amino acid positions essential for
polymerase activity were defined. The L mutants have
allowed the uncoupling of various steps in viral RNA
synthesis raising new questions about the mechanisms
involved in the multiple functions of the Sendai virus
polymerase complex, including the possibility of as yet
unidentified cofactors for specific steps. With another
family of the Mononegavirales, the Filoviridae, such a
cofactor has been identified. For the transcription and
genome replication of Marburg virus, three viral proteins,
comparable to the Sendai NP, P, and L proteins, are
sufficient. However, for Ebola virus the situation is quite
different (Muhlberger et al., 1999). When the three pro-
teins are added to the viral template, only genome rep-
lication takes place. To initiate viral transcription, a fourth
viral protein is necessary.
MATERIALS AND METHODS
Cells, viruses, and antibodies
A549 human lung carcinoma cells were used for all
experiments. Sendai virus (Harris strain) and its copy-
back defective interfering (DI) particle, DI-H, were prop-
agated in embryonated chicken eggs as previously de-
scribed (Carlsen et al., 1985). The DI-H RNA is 1410 nt
and contains the 5 terminus of the wt genome with a
portion of the L gene and a 3 end that is complementary
to 110 nt of the 5 end (Myers and Moyer, 1997). Poly-
merase-free nucleocapsid template (RNA-NP) was puri-
fied from both wt Sendai and DI-H viruses as described
previously (Horikami et al., 1992). A vaccinia virus recom-
binant which expresses the bacteriophage T7 RNA poly-
merase (VVT7) (Fuerst et al., 1986) was grown in CV-1
African green monkey kidney cells. Antibodies included
rabbit polyclonal anti-Sendai virus (-SV) (Horikami et al.,
1992), anti-P peptide (-P) (a kind gift of K. Gupta, Rush
Medical Center, Chicago, IL), and rabbit anti-trpE/SV L
fusion (-L) (Horikami et al., 1992).
Plasmids and mutagenesis
The pGem plasmids containing the Sendai virus NP,
P/C, and Pstop (expressing only P due to a stop codon in
the C open reading frames) genes under the control of
the T7 promoter were described previously (Curran et al.,
1991, 1994). The DI-H plasmid pSPDI-H expresses from
the T7 promoter a full-length DI-H ()-sense genomic
RNA, followed by the hepatitis delta ribozyme and a T7
terminator (Myers and Moyer, 1997). The specific L mu-
tations N734E, R736L, R736M, R736E, G737A, G737E,
G738M, G738F, and G741A were introduced into plasmid
pTM-L using the unique site elimination mutagenesis kit
(U.S.E., Amersham Pharmacia Biotech) on an L cDNA. All
other mutants were constructed using a modified proto-
col wherein the same assay a set of primers in which the
three nucleotide positions of the codon to be changed
were randomized. Using this procedure, up to eight dif-
ferent codons at one amino acid position could be gen-
erated. The sequence of the primers is available upon
request. Appropriate mutant fragments were sequenced
and recloned into pTML. The L mutant Q744K was con-
structed by PCR-based mutagenesis using Vent polymer-
ase (New England Biolabs) by the two-step method of
Higuchi (1990). The unique AvrII and AgeI sites were
used for cloning the fragment into pGem L at those sites
and the mutation was confirmed by sequencing.
Sendai virus transcription
A549 cells at 80% confluence in 60-mm dishes were
infected with VVT7 at a multiplicity of infection (m.o.i.) of
2.5 PFU/cell for 1 h at 37°C. The infected cells were
washed with Opti-MEM and transfected with wt P/C (1.5
g) and the wt or mutant L (0.2 g) plasmids in lipofectin
(Life Technologies) and incubated at 37°C in Opti-MEM
(Life Technologies). At 18 h posttransfection, cytoplasmic
extracts (100 l) were prepared using a modification of
the lysolecithin procedure (Horikami et al., 1992), where
the cells are scraped into incomplete reaction mix, mi-
crococcal nuclease digested, and then supplemented
with magnesium acetate, RNasin (Promega), actinomy-
cin D, creatine phosphate, and creatine phosphokinase
(Chandrika et al., 1995). To assay for mRNA synthesis, wt
Sendai RNA-NP template (1 g) and [32P]CTP (20 Ci)
were added to each extract. After incubation for 2 h at
30°C, the total labeled transcription products were puri-
fied over RNeasy columns (Qiagen) and analyzed by
electrophoresis on 1.5% agarose acid urea gels. The
products were visualized by autoradiography and quan-
titated using a PhosphorImager (Molecular Dynamics).
To assay for the 55-nt le product, extracts were
prepared as above except that the reaction mix con-
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tained 1 mM CTP and no radiolabeled nucleotide was
added. Sendai RNA-NP template (2.5 g) was added and
the samples incubated for 2 h at 30°C. Unlabeled total
transcripts were purified and then separated by electro-
phoresis on a 8% polyacrylamide/8 M urea gel. The RNA
was transferred onto Hybond-N nylon membrane (Amer-
sham Pharmacia Biotech). Leader transcripts were de-
tected using a 32P end-labeled Sendai virus le comple-
mentary oligonucleotide probe as previously described
(Horikami and Moyer, 1995), except that hybridization
was done at 40°C. The products were visualized by
autoradiography and quantitated on the Phosphor-
Imager.
Sendai virus replication
For in vitro replication analysis, VVT7-infected A549
cells were transfected at 1 h postinfection with Pstop (5
g), NP (2 g), and the wt or mutant L (0.2 g) plasmids.
At 18 h posttransfection lysolecithin extracts (100 l)
were prepared in incomplete reaction mix containing 10
M CTP with magnesium acetate and RNasin. After
pelleting the nuclei, actinomycin D was added, followed
by DI-H RNA-NP template (2 g) and [32P]CTP (50 Ci).
The samples were incubated at 30°C for 2 h and then
micrococcal nuclease treated to degrade all nucleic ac-
ids except encapsidated replication products. The RNAs
were purified with RNeasy columns, separated on aga-
rose acid urea gels, visualized, and quantitated. For in
vivo replication, VVT7-infected A549 cells were trans-
fected with the Pstop and NP and the wt or mutant L
plasmids as above with the addition of the genomic
pSPDI-H (2.5 g) plasmid. The mock sample contained
the pSPDI-H and pGem (7.2 g) plasmids. Lysolecithin
extracts were made in reaction mix salts [0.1 M HEPES
(pH 8.5), 50 mM NH4Cl, 7 mM KCl, 1 mM DTT] and
micrococcal nuclease treated. The unlabeled nuclease-
resistant products were purified over RNeasy columns
and separated on an agarose acid urea gel. The RNAs
were transferred to nylon membranes. The ()-strand
DI-H replication products were detected using an inter-
nally labeled ()-sense DI-H T7 transcript riboprobe.
Hybridization was done at 57°C and quantitated.
Protein analysis and the nucleocapsid binding assay
To monitor Sendai NP and P synthesis, samples (10 l)
of the extracts used for transcription and replication
were separated by 7.5% SDS–PAGE and transferred to
nitrocellulose. The blots were incubated with rabbit -SV
and -P peptide primary antibodies, followed by a horse-
radish peroxidase conjugated goat anti-rabbit secondary
antibody. Complexes were detected by chemilumines-
cence (ECL, Amersham Pharmacia Biotech) according to
the manufacturer’s protocol. To test for Sendai L expres-
sion, VVT7-infected cells in 35-mm dishes were trans-
fected at 1 h postinfection with P/C (1.67 g) and the wt
or mutant L (0.7 g) plasmids. At 4 h posttransfection the
cells were labeled overnight with 100 Ci/ml Tran35S-
label (NEN) in cysteine/methionine-free Dulbecco’s
MEM (Mediatech) supplemented with 10% MEM (Life
Technologies). Cytoplasmic cell extracts (165 l) were
prepared in 1% NP-40 lysis buffer (150 mM NaCl, 50 mM
Tris–HCl, pH 8.0, 1% NP-40, 1 g/ml aprotinin). After
pelleting at 13,000 rpm for 30 min at 4°C Sendai virus
proteins in the extracts (70 l) were immunoprecipitated
by incubation with a mixture of -SV and -L antibodies
(1 l each) and selected with inactivated Staphylococcus
aureus, Cowan strain, as described previously (Carlsen
et al., 1985). Immunoprecipitated labeled proteins were
separated by electrophoresis in 7.5% SDS–PAGE and
visualized by autoradiography.
Nonfunctional L mutants were tested for their ability to
form a complex with P protein and for complex binding to
the Sendai RNA-NP template by a sedimentation assay.
At 1 h postinfection VVT7-infected A549 cells in 60-mm
dishes were transfected in duplicate with P/C (4 g) and
the wt or selected mutant L (3.2 g) plasmids and incu-
bated at 37°C in Opti-MEM. At 4 h posttransfection the
cells were labeled for 1 h with 100 Ci/ml Tran35S-label
(Amersham) in cysteine/methionine-free Dulbecco’s
MEM. At 5 h posttransfection lysolecithin extracts (110
l) were made in reaction mix salts. After centrifugation
at 13,000 rpm at 4°C for 30 min, similar supernatants
were pooled and a 10-l aliquot was used for immuno-
precipitation. Nucleocapsid-binding assay samples (95
l) were incubated in the absence or presence of 1.5 g
wt Sendai RNA-NP (NC) for 30 min at 30°C. The samples
were then layered over a step gradient with 2.5 ml of 30
and 50% glycerol in 10 mM HEPES, pH 8.5/1 mM EDTA,
and pelleted in a SW55 rotor for 16 h at 14,400 rpm at
4°C. The nucleocapsid-containing pellets were collected
and separated by 7.5% SDS–PAGE, and the associated
proteins were visualized by autoradiography.
ACKNOWLEDGMENTS
This work was supported by NIH Grant AI 14594 (S.A.M.) and a grant
from the Deutsche Forschungsgesellschaft (W.J.N.).
REFERENCES
Cadd, T., Garcin, D., Tapparel, C., Itoh, M., Homma, M., Poux, L., Curran,
J., and Kolakofsky, D. (1996). The Sendai paramyxovirus accessory C
proteins inhibit viral genome amplification in a promoter-specific
fashion. J. Virol. 70, 5067–5074.
Carlsen, S. R., Peluso, R. W., and Moyer, S. A. (1985). In vitro replication
of Sendai virus wild-type and defective interfering particle genome
RNAs. J. Virol. 54, 493–500.
Chandrika, R., Horikami, S. M., Smallwood, S., and Moyer, S. A. (1995).
Mutations in conserved domain I of the Sendai virus L polymerase
protein uncouple transcription and replication. Virology 213, 352–
363.
Cortese, C. K., Feller, J. A., and Moyer, S. A. (2000). Mutations in domain
V of the Sendai virus L polymerase protein uncouple transcription
144 SMALLWOOD ET AL.
and replication and differentially affect replication in vitro and in vivo.
Virology 277, 387–396.
Curran, J., Boeck, R., and Kolakofsky, D. (1991). The Sendai virus P gene
expresses both an essential protein and an inhibitor of RNA synthe-
sis by shuffling modules via mRNA editing. EMBO J. 10, 3079–3085.
Curran, J., Marq, J.-B., and Kolakofsky, D. (1992). The Sendai virus
nonstructural C proteins specifically inhibit viral mRNA synthesis.
Virology 189, 647–656.
Curran, J., Marq, J.-B., and Kolakofsky, D. (1995). An N-terminal domain
of the Sendai paramyxovirus P protein acts as a chaperone for the
NP protein during the nascent chain assembly step of genome
replication. J. Virol. 69, 849–855.
Curran, J., Pelet, T., and Kolakofsky, D. (1994). An acidic activation-like
domain of the Sendai virus P protein is required for RNA synthesis
and encapsidation. Virology 202, 875–884.
Einberger, H., Mertz, R., Hofschneider, P. H., and Neubert, W. J. (1990).
Purification, renaturation and reconstituted protein kinase activity of
the Sendai virus large (L) protein: L protein phosphorylates the NP
and P proteins in vitro. J. Virol. 64, 4274–4280.
Feller, J. A., Smallwood, S., Horikami, S. M., and Moyer, S. A. (2000a).
Mutations in conserved domains IV and VI of the large (L) subunit of
the Sendai virus RNA polymerase give a spectrum of defective RNA
synthesis phenotypes. Virology 269, 426–439.
Feller, J. A., Smallwood, S., Skiadopoulos, M. H., Murphy, B. R., and
Moyer, S. A. (2000b). Comparison of identical temperature-sensitive
mutations in the L polymerase proteins of Sendai and parainfluenza
3 viruses. Virology 276, 190–201.
Fuerst, T. R., Niles, E. G., Studier, F. W., and Moss, B. (1986). Eukaryotic
transient-expression system based on recombinant vaccinia virus
that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl.
Acad. Sci. USA 83, 8122–8126.
Hammond, D. C., Haley, B. E., and Lesnaw, J. A. (1992). Identification
and characterization of serine/threonine protein kinase activity in-
trinsic to the L protein of vesicular stomatitis virus New Jersey. J. Gen.
Virol. 73, 67–75.
Hammond, O. C., and Lesnaw, J. A. (1987). Functional analysis of
hypomethylation variants of the New Jersey serotype of vesicular
stomatitis virus. Virology 160, 330–335.
Hercyk, N., Horikami, S. M., and Moyer, S. A. (1988). The vesicular
stomatitis virus L protein possesses the mRNA methyltransferase
activities. Virology 163, 222–225.
Higuchi, R. (1990). Recombinant PCR. In “PCR Protocols: A Guide to
Methods and Applications” (M. A. Innis, D. H. Gelfand, J. J. Sninsky,
and T. J. White, Eds.), pp. 177–183. Academic Press, New York.
Horikami, S. M., Curran, J., Kolakofsky, D., and Moyer, S. A. (1992).
Complexes of Sendai virus NP-P and P-L proteins are required for
defective interfering particle genome replication in vitro. J. Virol. 66,
4901–4908.
Horikami, S. M., Hector, R. E., Smallwood, S., and Moyer, S. A. (1997).
The Sendai virus C protein binds the L polymerase protein to inhibit
viral RNA synthesis. Virology 235, 261–270.
Horikami, S. M., and Moyer, S. A. (1995). Alternative amino acids at a
single site in the Sendai virus L protein produce multiple defects in
RNA synthesis in vitro. Virology 211, 577–582.
Hunt, D. M., and Hutchinson, K. L. (1993). Amino acid changes in the L
polymerase proteins of vesicular stomatitis virus which confer aber-
rant polyadenylation and temperature-sensitive phenotypes. Virology
193, 786–793.
Jin, H., and Elliott, R. M. (1992). Mutagenesis of the L protein encoded
by Bunyamwera virus and production of monospecific antibodies.
J. Gen. Virol. 73, 2235–2244.
Lamb, R. A., and Kolakofsky, D. (2001). Paramyxoviridae: The viruses
and their replication. In “Fundamental Virology” (D. M. Knipe, and
P. M. Howley, Eds.), 4th ed., pp. 689–724. Lippincott, Williams &
Wilkins, Philadelphia.
Muhlberger, E., Weik, M., Volchkov, V. E., Klenk, H. D., and Becker, S.
(1999). Comparison of the transcription and replication strategies of
Marburg virus and Ebola virus by using artificial replication systems.
J. Virol. 73, 2333–2342.
Mu¨ller, R., Poch, O., Delarue, M., Bishop, H. H. L., and Bouloy, M. (1994).
Rift valley fever virus L segment: Correction of the sequence and
possible functional role of newly identified regions conserved in the
RNA-dependent RNA polymerases. J. Gen. Virol. 75, 1345–1352.
Myers, T. M., and Moyer, S. A. (1997). An amino-terminal domain of the
Sendai virus nucleocapsid protein is required for template function in
viral RNA synthesis. J. Virol. 71, 918–924.
Poch, O., Blumberg, B. M., Bougueleret, L., and Tordo, N. (1990). Se-
quence comparison of five polymerases (L proteins) of unsegmented
negative-strand RNA viruses: Theoretical assignment of functional
domains. J. Gen. Virol. 71, 1153–1162.
Ryan, K. W., and Kingsbury, D. W. (1988). Carboxyl-terminal region of
Sendai virus P protein is required for binding to viral nucleocapsids.
Virology 167, 106–112.
Ryan, K. W., and Portner, A. (1990). Separate domains of Sendai virus P
protein are required for binding to viral nucleocapsids. Virology 174,
515–521.
Schnell, M. J., and Conzelmann, K. K. (1995). Polymerase activity of in
vitro mutated rabies virus L protein. Virology 214, 522–530.
Sidhu, M. S., Menonna, J. P., Cook, S. D., Dowling, P. C., and Udem, S. A.
(1993). Canine distemper virus L gene: Sequence and comparison
with related viruses. Virology 193, 50–65.
Sleat, D. E., and Banerjee, A. K. (1993). Transcriptional activity and
mutational analysis of recombinant vesicular stomatitis virus RNA
polymerase. Virology 67, 1334–1339.
Smallwood, S., Easson, C. D., Feller, J. A., Horikami, S. M., and Moyer,
S. A. (1999). Mutations in conserved domain II of the large (L) subunit
of the Sendai virus RNA polymerase abolish RNA synthesis. Virology
262, 375–383.
Tapparel, C., Hausmann, S., Pelet, T., Curran, J., Kolakofsky, D., and
Roux, L. (1997). Inhibition of Sendai virus genome replication due to
promoter-increased selectivity: A possible role for the accessory C
proteins. J. Virol. 71, 9588–9599.
Vidal, S., and Kolakofsky, D. (1989). Modified model for the switch from
Sendai virus transcription to replication. J. Virol. 63, 1951–1958.
145DOMAIN II AND III MUTATIONS IN SENDAI L PROTEIN
